| Previous Close | 35.45 |
| Open | 35.93 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 35.81 - 36.21 |
| 52 Week Range | 29.83 - 36.21 |
| Volume | 25,680,077 |
| Avg. Volume | 17,372,446 |
| Market Cap | 214.05B |
| Beta | 1.06 |
| PE Ratio (TTM) | 26.33 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.62%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- Motley Fool•2 hours ago
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real
Pfizer has filed a suit against Johnson & Johnson alleging that it has engaged in anticompetitive behavior to block market demand for Pfizer's Remicade biosimilar.
- The Wall Street Journal•2 hours ago
[$$] The Murky World of Drug Rebates Gets Airing in Lawsuit
The closely guarded world of drug pricing is getting a public airing in a feud between two of the industry’s biggest companies. The attention drawn to rebates could hurt the profits of some very successful ...
- The Wall Street Journal•2 hours ago
[$$] Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-Drug Copies
Pfizer filed suit against Johnson & Johnson alleging it has thwarted competition to its arthritis drug Remicade by effectively preventing health insurers, hospitals and clinics from offering Pfizer’s lower-priced ...
